Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06842134 · ClinicalTrials.gov registry record · Phase 1
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
A Phase 1 study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT06842134 is a Phase 1 study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 16 participants.
The verdict
NCT06842134, a Phase 1 study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a phase 1, prospective, single-center, randomized sequence, open label, 2-way crossover study comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E. It is planned to randomize approximately 16 healthy male and female subjects. All study periods will be completed during a single residency, the overall duration of residency will be 11 days (10 nights).
Interventions
- DRUG Numeta G16%E
- DRUG Sodium Glycerophosphate Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2025-05-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06842134
The ClinicalTrials.gov registry entry for NCT06842134 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Numeta G16%E is the first listed.
NCT06842134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06842134 about?
NCT06842134 is a clinical study titled "A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E". This is a phase 1, prospective, single-center, randomized sequence, open label, 2-way crossover study comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E. It is planned to randomize approximately 16 healthy male and female subjects. All study periods will be completed du...
What is the current status of trial NCT06842134?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2025-01-27. Estimated completion is 2025-05-22.
What interventions are being tested in trial NCT06842134?
The interventions under investigation include: Numeta G16%E (DRUG), Sodium Glycerophosphate Injection (DRUG).
Who is sponsoring clinical trial NCT06842134?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.